NEW YORK (GenomeWeb) – Genetic testing firm Color Genomics today launched with a $15 million private financing round and a $249 test for genes associated with breast and ovarian cancer. 

Based in Burlingame,Calif., the company said that it has begun offering the Color Test, a clinical-grade, comprehensive genetic sequencing test that analyzes 19 genes, including BRCA1 and BRCA2. Other genes on the panel include BARD1, PTEN, CDH1, and ATM, according to Color Genomics' website. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.